Xuchang Ketop Testing Research Institute Co.Ltd(003008) : announcement of abnormal fluctuations in stock trading (December 27, 2021)

Securities code: 003008 securities abbreviation: Xuchang Ketop Testing Research Institute Co.Ltd(003008) Announcement No.: 2021-064 Xuchang Ketop Testing Research Institute Co.Ltd(003008)

Stock trading abnormal fluctuation announcement

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

1、 Introduction to abnormal fluctuations in stock trading

The trading price of Xuchang Ketop Testing Research Institute Co.Ltd(003008) (hereinafter referred to as "the company") stock (Securities abbreviation: Xuchang Ketop Testing Research Institute Co.Ltd(003008) , securities code: 003008) has decreased by more than 20% in three consecutive trading days (December 22, 2021, December 23, 2021 and December 24, 2021), according to the trading rules of Shenzhen Stock Exchange The relevant provisions of the are abnormal fluctuations in stock trading. 2、 The company pays attention to and verifies the situation

In view of the abnormal fluctuation of the company's stock trading, the company has verified the relevant matters, and the relevant information is described as follows:

1. There is no need to correct or supplement the information disclosed by the company in the early stage;

2. The company has not found any unpublished material information that may or has had a great impact on the company's stock trading price reported by the public media recently;

3. Recently, the company's operation and internal and external business environment are normal without significant changes;

4. After verification and sending a letter to inquire about the shareholders holding more than 5% of the company's shares, as of the disclosure date of this announcement, the company and the shareholders holding more than 5% of the company have no major matters that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares, acquisition of listed companies, debt restructuring, business restructuring, asset stripping and asset injection, There are no major events in the planning stage;

5. After verification, the company sent a letter to ask the shareholders holding more than 5% of the company's shares. The shareholders holding more than 5% of the company did not buy or sell the company's shares during the abnormal fluctuation of shares.

3、 Whether there is a description of information that should be disclosed but not disclosed

The board of directors of the company confirms that, At present, the company does not have any matters that should be disclosed but not disclosed in accordance with the Listing Rules of Shenzhen Stock Exchange (hereinafter referred to as the Listing Rules) or the planning, negotiation, intention and agreement related to such matters; the board of directors has not been informed that the company has been in accordance with the listing rules And other relevant provisions that should be disclosed but not disclosed, which has a great impact on the trading price of the company's shares and their derivatives; There is no need to correct or supplement the information disclosed by the company in the early stage.

4、 Risk tips

1. Through self-examination, the company does not violate the fair disclosure of information;

2. According to the requirements of the company law, the securities law and other relevant laws and regulations, the company will truthfully, accurately, timely, completely and fairly disclose major information that may affect the company's stock price to investors for investment judgment. Limited by objective conditions, the company is unable to grasp the causes and trends of stock market changes. The company reminds investors to pay attention to stock price fluctuations and possible risks in the stock market in the future;

3. The company's operating revenue in the first three quarters of 2021 was 98980648.41 yuan, a decrease of 17.33% over the same period of last year; The net profit attributable to the shareholders of the listed company was 48913617.01 yuan, a decrease of 27.69% over the same period of the previous year. Please invest rationally and pay attention to risks;

4. The company solemnly reminds investors: securities times, China Securities News, Shanghai Securities News, securities daily and cninfo( http://www.cn.info.com..cn. )As the information disclosure media selected by the company, all information of the company shall be subject to the information published in the above media. Please invest rationally and pay attention to risks.

It is hereby announced.

Xuchang Ketop Testing Research Institute Co.Ltd(003008) board of directors

December 24, 2021

 

- Advertisment -